Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Kirsten Vormbrock"'
Autor:
Anne Kölsch, Tana Omokoko, Claudia Paret, Özlem Türeci, Diana Barea Roldan, Christoph Hartmann, Ugur Sahin, Christian Bender, Andrea Breitkreuz, Kirsten Vormbrock, Abderaouf Selmi, Meike Wagner, Stefanie Hubich-Rau, Petra Simon, Sabine Häcker, Özlem Yildiz
Publikováno v:
Oncotarget
// Claudia Paret 1 , Petra Simon 2 , Kirsten Vormbrock 1 , Christian Bender 1 , Anne Kolsch 1 , Andrea Breitkreuz 2 , Ozlem Yildiz 2 , Tana Omokoko 2 , Stefanie Hubich-Rau 3 , Christoph Hartmann 1, 3 , Sabine Hacker 1 , Meike Wagner 1, 3 , Diana Bare
Autor:
Rajan Somasundaram, Michael Höpfner, Detlef Schuppan, Bernhard Heine, Kerstin Maaser, Harald Stein, Martin Zeitz, Antje Krahn, Gesine Bradacs, Hans Scherübl, Kirsten Vormbrock, Patricia Grabowski, Andreas P. Sutter
Publikováno v:
Journal of Hepatology. 41:799-807
Background/Aims Hepatocellular carcinoma (HCC) is one of the most common causes of cancer deaths worldwide. Thus, novel therapies are urgently needed. A promising approach is the use of peripheral benzodiazepine receptor (PBR) ligands which inhibit t
Publikováno v:
Methods in molecular biology (Clifton, N.J.). 878
The process of how a benign tumour turns invasive and capable to survive in distant organs remains poorly understood, despite the evidence that metastasis formation is the primary cause of cancer patient mortality. This ignorance is partly due to the
Publikováno v:
Methods in Molecular Biology ISBN: 9781617798535
The process of how a benign tumour turns invasive and capable to survive in distant organs remains poorly understood, despite the evidence that metastasis formation is the primary cause of cancer patient mortality. This ignorance is partly due to the
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::e132339c65d7119f699c190b4174556d
https://doi.org/10.1007/978-1-61779-854-2_14
https://doi.org/10.1007/978-1-61779-854-2_14
Publikováno v:
Cancer Research. 69:C36-C36
The retinoblastoma tumor suppressor protein (pRb) was the first tumor suppressor to be identified. The E2F family of transcription factors is considered the best-studied class of interaction partners of pRB. Specifically, E2F1-3 are all capable to co